CVS Health Co. (NYSE:CVS) Shares Purchased by Forsta AP Fonden

Forsta AP Fonden boosted its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 9.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 375,600 shares of the pharmacy operator's stock after acquiring an additional 32,600 shares during the quarter. Forsta AP Fonden's holdings in CVS Health were worth $16,861,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health in the 3rd quarter valued at about $25,000. Ridgewood Investments LLC lifted its position in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after buying an additional 450 shares in the last quarter. Livelsberger Financial Advisory purchased a new stake in CVS Health in the 3rd quarter valued at $31,000. Legacy Investment Solutions LLC acquired a new stake in shares of CVS Health in the 3rd quarter worth $31,000. Finally, Reston Wealth Management LLC purchased a new position in shares of CVS Health during the 3rd quarter worth $32,000. Institutional investors and hedge funds own 80.66% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on CVS shares. Evercore ISI raised their price objective on shares of CVS Health from $60.00 to $65.00 and gave the stock an "outperform" rating in a research report on Monday. TD Cowen lifted their target price on CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a research report on Monday, November 25th. Piper Sandler reduced their price objective on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a report on Monday, November 25th. Truist Financial lowered their target price on shares of CVS Health from $67.00 to $60.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Finally, Royal Bank of Canada reduced their price target on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a research note on Friday, November 15th. One analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $68.12.

CVS Health Stock Down 1.4 %

NYSE:CVS traded down $0.80 during mid-day trading on Thursday, hitting $56.10. The stock had a trading volume of 3,744,610 shares, compared to its average volume of 13,112,369. The company has a market capitalization of $70.60 billion, a PE ratio of 14.24, a PEG ratio of 0.80 and a beta of 0.59. The stock has a 50-day simple moving average of $51.28 and a two-hundred day simple moving average of $56.17. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same quarter last year, the company posted $2.21 earnings per share. The business's quarterly revenue was up 6.3% compared to the same quarter last year. On average, equities research analysts anticipate that CVS Health Co. will post 5.22 EPS for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be given a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.74%. CVS Health's dividend payout ratio (DPR) is 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.